We further show that this upregulation of MYC is mediated by BRD4 regulation of the MYC gene and that combining a BRD4 inhibitor with everolimus leads to enhanced tumor growth inhibition in vitro and in vivo. The gene discussed is BRD4; the disease is neoplasm.